Can-Fite BioPharma Ltd.
CANF
$1.20
-$0.03-2.44%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.96M | -1.96M | -1.98M | -1.98M | -- |
| Total Depreciation and Amortization | 3.00K | 3.00K | 500.00 | 500.00 | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 66.50K | 66.50K | 185.00K | 185.00K | -- |
| Change in Net Operating Assets | 91.50K | 91.50K | -225.00K | -225.00K | -- |
| Cash from Operations | -1.80M | -1.80M | -2.02M | -2.02M | -- |
| Capital Expenditure | -500.00 | -500.00 | -2.00K | -2.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.50M | -1.50M | 2.25M | 2.25M | -- |
| Cash from Investing | -1.50M | -1.50M | 2.25M | 2.25M | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.61M | 3.61M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -256.00K | -256.00K | -- | -- | -- |
| Cash from Financing | 3.36M | 3.36M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -1.50K | -1.50K | -9.50K | -9.50K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.00K | 53.00K | 220.50K | 220.50K | -- |